Adequacy of Size Matching With Predicted Heart Mass Ratio in Diverse Types of Cardiomyopathies

Roh Yanagida1, Ahad Firoz2, Mohammed Kashem1

  • 1Division of Cardiovascular Surgery, Department of Surgery, Temple University Hospital, Philadelphia, PA.

PubMed

Insights

Predicted heart mass ratio (PHMr) size matching for donor hearts is not uniform across all cardiomyopathies. Undersized hearts decreased survival in dilated and valvular disease, but not hypertrophic, restrictive, or congenital heart disease.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Statistics

Background:

  • Predicted heart mass ratio (PHMr) is a proposed metric for donor heart size selection.
  • The uniform applicability of PHMr across different cardiomyopathy etiologies remains unconfirmed.

Purpose of the Study:

  • To investigate whether size matching criteria based on PHMr impacts survival outcomes uniformly across diverse cardiomyopathy types in heart transplant recipients.
  • To identify specific cardiomyopathy groups where PHMr-based size matching is less critical for survival.

Main Methods:

  • Analysis of the United Network for Organ Sharing registry database (1987-2021) including 53,573 heart transplant recipients.
  • Categorization of recipients into six cardiomyopathy groups: dilated, coronary artery disease, hypertrophic, restrictive, valvular, and adult congenital heart disease.
  • Stratification of patients by PHMr into five size categories (severely undersized to severely oversized) to assess survival and cause of death.

Main Results:

  • Recipients with dilated and valvular cardiomyopathy receiving undersized hearts (PHMr <0.86) exhibited decreased survival compared to size-matched controls.
  • Survival outcomes for patients with hypertrophic, restrictive cardiomyopathy, or adult congenital heart disease were not significantly affected by size matching based on PHMr.
  • Hazard ratios indicated significant survival decrements for undersized hearts in dilated (1.17, p=0.001) and valvular (1.79, p=0.032) cardiomyopathies.

Conclusions:

  • The effectiveness of PHMr for donor heart size matching is not uniform across all cardiomyopathy etiologies.
  • Current size matching criteria may be overly restrictive for certain conditions.
  • Findings suggest increased donor heart acceptance rates are possible for patients with hypertrophic, restrictive cardiomyopathy, and congenital heart disease where size matching is less critical for survival.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12